Featured Research

from universities, journals, and other organizations

Study Points To Potential Role For Caffeine In Reducing The Risk Of Parkinson's Disease

Date:
May 7, 2001
Source:
Massachusetts General Hospital
Summary:
Coffee drinkers who worry that their morning fix might not be the healthiest of habits may find comfort in a recent report. Working with a mouse model of Parkinson's disease, scientists at Massachusetts General Hospital (MGH) have shown that caffeine is able to prevent the loss of the chemical signal that is depleted in Parkinson’s disease.

BOSTON — May 3, 2001 — Coffee drinkers who worry that their morning fix might not be the healthiest of habits may find comfort in a recent report. Working with a mouse model of Parkinson's disease, scientists at Massachusetts General Hospital (MGH) have shown that caffeine is able to prevent the loss of the chemical signal that is depleted in Parkinson’s disease. Published in the May 15th Journal of Neuroscience, the study links caffeine's effects to the A2A receptor located on neural cells next to those that degenerate in Parkinson's patients.

A2A receptors, which bind the molecule adenosine, are found in distinct areas of the brain, and their expression is restricted to the very cells that are targets of the dopaminergic neurons that go awry in Parkinson's disease. "The A2A receptor has a distinct advantage when it comes to treatment because it exists for the most part where you want to target your therapy. So there may be fewer side effects," says Michael A. Schwarzschild, MD, PhD, assistant professor of Neurology at MGH and principal investigator.

Caffeine acts as an antagonist to the A2A receptor, blocking its binding site and rendering it inactive. The scientists found that the effects of caffeine were mimicked by several known A2A antagonists as well as by genetic inactivation of the A2A receptor.

The mouse study adds to epidemiological data published last year that documented how much coffee people drank and compared it to whether they developed Parkinson’s. According to Schwarzschild, the results indicate that caffeine may be linked to a decreased risk of Parkinson’s.

"Once this association was found, people asked if caffeine had an effect on the disease, or rather, does Parkinson’s have an effect on caffeine consumption," says Jiang-Fan Chen, MD, PhD, assistant professor of Neurology at MGH and scientific co-director of the project. In other words, perhaps a brain destined to be affected by Parkinson’s also is resistant to caffeine addiction.

The current study does not support this theory, though, as it shows that caffeine can prevent the biochemical hallmark of Parkinson’s in the mouse model. "The animal results lend more weight to caffeine’s neuroprotective nature," says Schwarzschild. "But the results don’t prove it, and they do not provide a rationale for changing caffeine consumption habits." Time will tell if the mouse data will translate to humans, he says.

For their studies, Schwarzschild and his team used a mouse model that mimics the features of Parkinson's disease—namely, neural degeneration in the brain associated with a depletion of the neurotransmitter dopamine. Mice exposed to a chemical called MPTP can develop Parkinson's-like symptoms because MPTP causes a decrease in brain dopamine. When the researchers pretreated the mice with caffeine (at levels that would equal about a cup or two of coffee to humans), their brain dopamine levels remained near normal, and thus the MPTP toxicity was decreased.

Interestingly, caffeine's neuroprotective effect may be closely linked to its stimulatory effect. Genetically altered mice that lack A2A receptors experience none of the motor stimulation for which caffeine is so well known.

Dopamine replacement is the standard treatment for Parkinson's disease today. Despite this treatment, the disease continues to progress, often accompanied by motor side effects of the therapy. A2A receptor antagonists can enhance motor function and perhaps even slow disease progression without these complications. "If caffeine is protective through the A2A receptor, more discrete targeting of this receptor may be a good therapy," says Schwarzschild. A2A receptor antagonists are now entering human trials for the treatment of Parkinson's disease. "I look forward to seeing if this basic science lead will be relevant to clinical care," says Schwarzschild.

A complementary paper by Harvard researchers that looks at extensive epidemiological data on caffeine consumption and Parkinson's disease will also be published this month in the Annals of Neurology. The study found that men who regularly drank coffee had a significantly decreased risk of developing Parkinson' s disease. For women, there was a U-shaped correlation, with the lowest risk of developing the disease among women who consumed moderate amounts of coffee (one to three cups a day). Alberto Ascherio, MD, DrPH, of the Harvard School of Public Health, and Walter C. Willett, MD, DrPH, of Brigham and Women’s Hospital, pioneered the work. Schwarzschild together with Chen is collaborating with these researchers and says: "We now have close discussions to see how epidemiological studies can inform our laboratory studies and vice versa. This interdisciplinary approach is very exciting." Schwarzschild says he hopes that looking at Parkinson’s from different angles may shed light on the development of the disease and offer insight concerning treatment and prevention.

The Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $300 million and major research centers in AIDS, the neurosciences, cardiovascular research, cancer, cutaneous biology, transplantation biology and photo-medicine. In 1994, the MGH joined with Brigham and Women’s Hospital to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups and nonacute and home health services.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Study Points To Potential Role For Caffeine In Reducing The Risk Of Parkinson's Disease." ScienceDaily. ScienceDaily, 7 May 2001. <www.sciencedaily.com/releases/2001/05/010507081823.htm>.
Massachusetts General Hospital. (2001, May 7). Study Points To Potential Role For Caffeine In Reducing The Risk Of Parkinson's Disease. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2001/05/010507081823.htm
Massachusetts General Hospital. "Study Points To Potential Role For Caffeine In Reducing The Risk Of Parkinson's Disease." ScienceDaily. www.sciencedaily.com/releases/2001/05/010507081823.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins